Global Tyrosine Kinase JAK Inhibitors Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3477896
- 93 Pages
- February 2020
- Healthcare
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Tyrosine Kinase JAK Inhibitors market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Tyrosine Kinase JAK Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tofacitinib
Ruxolitinib
Baricitinib
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Tyrosine Kinase JAK Inhibitors Industry
Figure Tyrosine Kinase JAK Inhibitors Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Tyrosine Kinase JAK Inhibitors
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Tyrosine Kinase JAK Inhibitors
1.2.2 Downstream
Table Application Segment of Tyrosine Kinase JAK Inhibitors
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Tyrosine Kinase JAK Inhibitors Market by Type
3.1 By Type
3.1.1 Tofacitinib
Table Major Company List of Tofacitinib
3.1.2 Ruxolitinib
Table Major Company List of Ruxolitinib
3.1.3 Baricitinib
Table Major Company List of Baricitinib
3.2 Market Size
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Type, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2015-2019, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Type, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Pfizer (Company Profile, Sales Data etc.)
4.1.1 Pfizer Profile
Table Pfizer Overview List
4.1.2 Pfizer Products & Services
4.1.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Incyte (Company Profile, Sales Data etc.)
4.2.1 Incyte Profile
Table Incyte Overview List
4.2.2 Incyte Products & Services
4.2.3 Incyte Business Operation Conditions
Table Business Operation of Incyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis (Company Profile, Sales Data etc.)
4.3.1 Novartis Profile
Table Novartis Overview List
4.3.2 Novartis Products & Services
4.3.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eli Lilly (Company Profile, Sales Data etc.)
4.4.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.4.2 Eli Lilly Products & Services
4.4.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Gilead (Company Profile, Sales Data etc.)
4.5.1 Gilead Profile
Table Gilead Overview List
4.5.2 Gilead Products & Services
4.5.3 Gilead Business Operation Conditions
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sanofi (Company Profile, Sales Data etc.)
4.6.1 Sanofi Profile
Table Sanofi Overview List
4.6.2 Sanofi Products & Services
4.6.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Galapagos (Company Profile, Sales Data etc.)
4.7.1 Galapagos Profile
Table Galapagos Overview List
4.7.2 Galapagos Products & Services
4.7.3 Galapagos Business Operation Conditions
Table Business Operation of Galapagos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 AbbVie (Company Profile, Sales Data etc.)
4.8.1 AbbVie Profile
Table AbbVie Overview List
4.8.2 AbbVie Products & Services
4.8.3 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Vertex (Company Profile, Sales Data etc.)
4.9.1 Vertex Profile
Table Vertex Overview List
4.9.2 Vertex Products & Services
4.9.3 Vertex Business Operation Conditions
Table Business Operation of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva (Company Profile, Sales Data etc.)
4.10.1 Teva Profile
Table Teva Overview List
4.10.2 Teva Products & Services
4.10.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Astellas Pharma (Company Profile, Sales Data etc.)
4.11.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.11.2 Astellas Pharma Products & Services
4.11.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Celgene (Company Profile, Sales Data etc.)
4.12.1 Celgene Profile
Table Celgene Overview List
4.12.2 Celgene Products & Services
4.12.3 Celgene Business Operation Conditions
Table Business Operation of Celgene (Sales Revenue, Cost, Gross Margin)
4.13 CTI BioPharma (Company Profile, Sales Data etc.)
4.13.1 CTI BioPharma Profile
Table CTI BioPharma Overview List
4.13.2 CTI BioPharma Products & Services
4.13.3 CTI BioPharma Business Operation Conditions
Table Business Operation of CTI BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue 2015-2019, by Company, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share in 2019, by Company, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume 2015-2019, by Company, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Tyrosine Kinase JAK Inhibitors Market Concentration, in 2019
Figure Europe Tyrosine Kinase JAK Inhibitors Market Market Concentration, in 2019
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors MMarket Concentration, in 2019
Figure South America Tyrosine Kinase JAK Inhibitors Market Concentration, in 2019
Figure Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Rheumatoid Arthritis (RA)
Figure Tyrosine Kinase JAK Inhibitors Demand in Rheumatoid Arthritis (RA), 2015-2019, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Rheumatoid Arthritis (RA), 2015-2019, in Volume
6.1.2 Demand in Polycythemia Vera (PCV)
Figure Tyrosine Kinase JAK Inhibitors Demand in Polycythemia Vera (PCV), 2015-2019, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Polycythemia Vera (PCV), 2015-2019, in Volume
6.1.3 Demand in Myelofibrosis (MF)
Figure Tyrosine Kinase JAK Inhibitors Demand in Myelofibrosis (MF), 2015-2019, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Myelofibrosis (MF), 2015-2019, in Volume
6.1.4 Demand in Others
Figure Tyrosine Kinase JAK Inhibitors Demand in Others, 2015-2019, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2020-2025, by Application, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Market Growth 2020-2025, by Application, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Market Share in 2025, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2020-2025, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Growth 2020-2025, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Tyrosine Kinase JAK Inhibitors Production 2015-2019, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Share 2015-2019, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Region, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure North America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table North America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Europe Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Europe Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure South America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table South America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Tyrosine Kinase JAK Inhibitors
Table Application Segment of Tyrosine Kinase JAK Inhibitors
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2025, by Application, in USD Million
Table Major Company List of Ruxolitinib
Table Major Company List of Baricitinib
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Type, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Type, in Volume
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Incyte Overview List
Table Business Operation of Incyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Overview List
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galapagos Overview List
Table Business Operation of Galapagos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vertex Overview List
Table Business Operation of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Business Operation of Celgene (Sales Revenue, Cost, Gross Margin)
Table CTI BioPharma Overview List
Table Business Operation of CTI BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue 2015-2019, by Company, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume 2015-2019, by Company, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2020-2025, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2020-2025, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Growth 2020-2025, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Share in 2025, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Production 2015-2019, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Production 2015-2019, by Region, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Share 2015-2019, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2015-2019, by Region, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Share 2015-2019, by Region, in Volume
Table North America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table North America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
Table Europe Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Europe Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
Table South America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table South America Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size 2015-2019, by Country, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
